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We have examined hydrophobic properties of Tetrahymena CaM using the uncharged probe, 
n-phenyl-1-naphthylamine (NPN) fluorescence. The maximal fluorescence intensity of Tetrahymena 
calmodulin (CaM) is <l/12 of that of the bovine brain CaM. In the phosphodiesterase activation, the 
potency of Tetrahymena CaM, which was represented by reciprocals of the quantity of CaM required for 
half-maximal activation of enzyme was 22.7% respectively, of that of the bovine brain CaM. Here, 
Tetrahymena CaM had less hydrophobic groups exposed in the presence of Ca2’. Then Ca’+-CaM 
dependent enzymes require much amount of Tetrahymena CaM, comparing with the bovine brain CaM. 
Tetrahymena pyriformis Calmodulin 
N-Phenyl-I-naphthylamine 
1. INTRODUCTION 
In [l] it was noted that the activity of membrane- 
bound guanylate cyclase from Tetruhymena pyri- 
formis was activated by an endogenous protein, in 
the presence of Ca’+. This activator protein proved 
to be a Ca’+-binding protein of acidic and thermo- 
stable nature and attention was given to the possi- 
bility that this compound was calmodulin (CaM) 
[I]. As this protein activated Ca’+-CaM-depen- 
dent phosphodiesterase to a lesser extent than did 
bovine brain CaM, the question followed as to why 
Ca2+-CaM-dependent phosphodiesterase r quires 
a larger amount of Tetrahymena CaM, compared 
with bovine brain CaM. 
A variety of techniques used to demonstrate 
Ca2+-induced conformational change in CaM 
include optical rotatory dispersion [2], circular 
Abbreviations: CaM, calmodulin; NPN, N-phenyl-l- 
naphthylamine; EGTA, ethylene glycol bis (P-aminoethyl 
ether)-N,N,N ‘,N ‘-tetraacetic acid 
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Ca’+-CaMdependent phosphodiesterase 
Hydrophobicity Calcium 
dichroism [3], differential sensitivity to proteolysis 
[4], differential sensitivity to chemical modification 
[2], absorption spectroscopy [5] and enhancement 
of tyrosine fluorescence [6]. Finally, the func- 
tional significance of Ca2+-induced conformational 
change was explained on the basis that the exposed 
hydrophobic groups of CaM were related to the 
activation of Ca2+-CaM-dependent enzymes, de- 
termined using several hydrophobic probes [7,8]. 
We now report that Tetrahymena CaM has 
fewer hydrophobic groups exposed in the presence 
of Ca2+, thus, Ca2+-CaM-dependent enzymes re- 
quire a larger amount of Tetrahymena CaM com- 
pared with bovine brain CaM. 
2. MATERIALS AND METHODS 
2.1. Protein 
Calmodulin (CaM) of bovine brain and Tetra- 
hymena was purified as in [1,9]. The preparations 
were assessed to be homogenous by sodium do- 
decylsulfate-polyacrylamide gel electrophoresis. 
CaM-deficient Ca2+-dependent 3’ : 5’-cyclic nucleo- 
tide phosphodiesterase from bovine brain was par- 
tially prepared as in [5]. 
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2.2. Fluorescence measurements 
Fluorescence measurements were made at room 
temperature (22°C) using microcuvettes with an 
Aminco-Bowman fluorescence spectrophotometer 
with a high stability xenon lamp scanning from 
360-600 nm. Total dilution never exceeded 5% 
and relative fluorescence values were uniformly 
corrected for dilution. N-phenyl-1-naphthylamine 
(NPN) was dissolved in 100% ethanol, and concen- 
tration of ethanol in the samples undergoing meas- 
urement was never >OS%. 
2.3. Activity of bovine brain cyclic nucleotide 
phosphodiesterase 
Activity of bovine brain cyclic nucleotide phos- 
phodiesterase using cyclic GMP as substrate was 
measured as in [lo]. 
2.4. Protein determination 
Protein was determined as in [ 111, with purified 
CaM as a standard. 
3. RESULTS 
3.1. Phosphodiesterase activity of Tetrahymena 
Cakf and bovine brain CaM 
Tetrahymena nd bovine brain CaM’s activated 
CaM-deficient brain phosphodiesterase in the pre- 
CALMODULIN (ng/tube) 
Fig. 1. Effect of the bovine brain CaM (-o-) and the Fig.2. The bovine brain CaM and the Tetrahymena CaM 
Tetrahymena CaM (-o-) on the activity of Ca’+-CaM- interact with NPN in the presence of 20gM Ca2+ 
dependent phosphodiesterase. Theresult is expressed as (- ) (- - - -), and 1 mM EGTA (- - -) (-----). Solu- 
a % of maximal activation plotted against the amount of tions contained 50 mM Tris-HCl (pH 7.6) 10 PM CaM 
CaMs (ng/tube) added. and 10 LLM NPN. 
sence of Ca2+ (fig.1). Although the extent of the 
maximal activation of phosphodiesterase produced 
by Tetrahymena CaM was comparable to that of 
bovine brain CaM, the amount of CaM required 
for half-maximal activation of the enzyme differed. 
In the activation by phosphodiesterase, the potency 
of Tetrahymena CaM represented by reciprocals of 
the quantity of CaM required for half-maximal 
activation of enzyme was 22.7% bovine brain CaM. 
The concentrations of Ca2+ required for half- 
maximal activation of enzyme were 2 and 4 PM with 
bovine brain tetrahymena CaMs (not shown) [l]. 
3.2. Interaction between n-phenyl-I-napthylamine 
(NPN) and CaM 
Fig.2 shows that the bovine brain CaM and 
Tetrahymena CaM interact with NPN in the pre- 
sence of 20 pM Ca2+. The fluorescence at 420 nm 
of NPN in the presence of two proteins was negli- 
gible with 21 PM Ca2+ in the reaction mixture. 
Ca2+ increased the quantum yield and a ‘blue shift’ 
occurred in the emission peaks. In the absence of 
CaM, Ca2+ had no effect on the fluorescence of 
NPN. When the effect of Ca2+ concentration on 
the interaction was studied using the Ca2+-EGTA 
buffer system, the NPN fluorescence was maximal 
with 20pM Ca2+ in the bovine brain CaM, and 
with 5 PM Ca2+ it was maximal with 20 PM Ca2+ 
EMSSION WAVELENGTH (nm) 
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Fig.3. NPN fluorescence increased as a function of Ca2+ 
concentration i the presence of the bovine brain CaM 
(u) and the Tetruhymena CaM (-o-). Solutions 
contained 50 mM Tris-HCl (pH 7.6) 10 ,uM CaM, 
1OpM NPN and Ca’+-EGTA buffer as indicated. 
in Tetrahymena CaM. The maximum fluorescence 
intensity of Tetrahymena CaM was <l/12 that of 
the bovine brain CaM (fig.2). Addition of excess 
EGTA of the NPN-CaM complex or dialysis of 
the complex reduced the fluorescence significantly 
and re-addition of Ca2+ and NPN increased the 
fluorescence, suggesting the reversibility of inter- 
action between NPN and the Ca’+-CaM complex. 
In the presence ofpM levels of Ca2+, a hydrophobic 
site of CaM becomes accessible to NPN. Our 
findings show that Tetrahymena CaM has fewer 
hydrophobic groups exposed in the presence of 
Ca’+, compared with bovine brain CaM. The 
Ca’+-CaM-dependent phosphodiesterase r quires 
larger amounts of Tetrahymena CaM than does 
bovine brain CaM. 
4. DISCUSSION 
Ca’+-CaM-dependent enzymes such as Ca’+- 
dependent cyclic nucleotide phosphodiesterase [ 12, 
131, myosin light-chain kinase [ 141, and the erytho- 
cyte Ca’+-ATPase [15] can be activated by the 
addition of acidic phospholipids or of fatty acids. 
These phenomena suggested to us that Ca2+-CaM 
interacts hydrophobically with Ca2+-CaM-depen- 
dent enzymes. 
A number of amphiphilic cationic antipsychotic 
drugs bind to CaM and inhibit CaM stimulation 
of the Ca2+-sensitive phosphodiesterase [ 161. Al- 
though some antipsychotic drugs exhibit stereo- 
specificity for certain in vitro and in vivo effects, 
binding to CaM, and inhibition of CaM stimula- 
tion of phosphodiesterase were not nearly so stereo- 
specific [ 171. Recently, we found that change in the 
affinity of antagonists for CaM correlates well 
with change in the hydrophobicity, determined by 
using 3 series of naphthalenesulfonamide deriva- 
tives [18]. 
The fluorescence intensity of NPN increased 
dramatically in the presence of Ca2+ and calmodu- 
lin. With this ligand, there was a significant shift in 
the emission spectrum to a shorter wave-length. In 
contrast, CaM had only a slight effect on the emis- 
sion spectra of this probe, in the presence of 
EGTA, and Ca2+ alone had no effect on the fluor- 
escence of this ligand. This spectral change is con- 
sistent with findings in case of removal of the 
fluorescent dye from an aqueous environment to 
hydrophobic binding sites on the protein [19]. 
These results show that the activities of Tetra- 
hymena and bovine brain CaMs for Ca’+-CaM- 
dependent phosphodiesterase correlate well with 
amount of the exposed hydrophobic groups of 
CaMs in the presence of Ca2+. 
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